Tag Archives: Jeremy Hunt

The challenge remains: healthcare needs reform

Posted on July 15, 2016 by

Comment by Robin Millar, Acting Chief Executive, 2020health On a day of changing faces around the Cabinet table, the Prime Minister has retained Jeremy Hunt as Secretary of State for Health – and he has retained the challenge of reforming the NHS. The pressures … Continue reading →

Posted in EU, Health and Wellbeing, Health reform, Jeremy Hunt, NHS, NHS England, NHS reforms, Public Health | Tagged , , , , | Leave a comment

NHS Costs and charging: Publicity, shame and complexity

Posted on July 3, 2015 by

Commenting on today’s press about Jeremy Hunt has created waves with his new plan to state the cost of medicines on the label and with his comment last night (July 2nd) on Question Time that he is not opposed to … Continue reading →

Posted in Finance | Tagged , , , , , , | Leave a comment

How can A&E units improve their performance?

Posted on January 29, 2015 by

The first point that I must make is that I do not wish to appear unappreciative or condescending. Hospital A&E work is amongst the most important that any person can undertake and many of us would find the strain unbearable. … Continue reading →

Posted in A&E, Department of Health, Elderly, GPs, Hospitals, NHS, Patients | Tagged , , , , , , , , , , , , , ,

Extraordinary confessions, a rare strike and a plan

Posted on October 13, 2014 by

It’s busy in health news today. There’s the NHS strike over pay –  the BBC’s Norman Smith has just reported (at 7.40am) that “Health sec Jeremy Hunt says will sit down and negotiate with NHS unions if they agree to … Continue reading →

Posted in NHS reforms, Obesity | Tagged , , , , , , , | Leave a comment

Medical advisory body “NICE” should not spend too much time valuing drugs.

Posted on April 14, 2014 by

The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading →

Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Age should not be a factor in cancer treatment

Posted on January 24, 2014 by

For Christmas my daughter bought me Jodie Picoult’s moving novel ‘My Sister’s keeper’, the story of a girl who is genetically selected to be born as a bone-marrow donor match to treat her older sister Kate’s leukemia. Kate relapses as … Continue reading →

Posted in Bowel Cancer, Breast Cancer, Cancer, Finance | Tagged , , , , , , , , , , | Leave a comment

Guest Blogspot: Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry.

Posted on December 4, 2013 by

The UK Government and the pharmaceutical industry shared many objectives throughout the recent drug pricing negotiations. For example, there was always broad agreement that: The total future drug bill needed to be affordable in the context of other spending in … Continue reading →

Posted in Andrew Lansley, Business, Cancer, Department of Health, Drugs, Innovation, Jeremy Hunt, NHS, Patients, Pharma, Research, Smoking ban | Tagged , , , , , , , , , , , , , , , , , , , , , , | 1 Comment